Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transdermal formulation of xanomeline

Transdermal formulation of xanomeline

US Patent 5980933 · Granted Nov 9, 1999

Estimated economic value: $103,079,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Transdermal therapeutic system for administering water-soluble peptides and poly2023
Crystalline compounds2022
Water-vapor-permeable adhesive bandages2022
Drug disposal devices and methods of use2021
Composition for transdermal delivery of cationic active agents2021
Composition for transdermal delivery of cationic active agents2021
Crystalline compounds2020
Transdermal therapeutic system for the administration of peptides2020
Transdermal therapeutic system comprising active ingredient particles and having2020
Transdermal therapeutic system for the administration of peptides2019
Transdermal administration of memantine2019
Device with transdermal therapeutic system, and positioning aid and penetration 2019